What does CUSIP 46333XAD0 represent in this 13F holders report?

CUSIP 46333XAD0 is the security identifier for 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 used to aggregate holder disclosures.

How many institutions held 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in Q2 2022?

No institutional holders were reported for 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in Q2 2022; review adjacent reporting periods for trend context.

IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Debt / DBCV 2.250% 6/1
Total 13F principal: $0
Principal change: -$109,604,000
Total reported market value: $0
Number of holders: 0
Value change: -$111,251,427
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2022

Recent filing periods for CUSIP 46333XAD0:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

Q2 2022 13F Holders as of 30 Jun 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q2 2022.